Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein

被引:16
作者
Ausubel, LJ
Bieganowska, KD
Hafler, DA
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
autoimmunity; T-cell receptor; multiple sclerosis; immunotherapy; peptide/antigens;
D O I
10.1006/cimm.1998.1447
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have determined that certain altered peptide Ligands (APLs) can induce T-cells specific for the native peptide myelin basic protein (MBP) p85-99 to secrete Th2-type cytokines such as IL-4 and IL-5 in the absence of significant Th1-type cytokines. However, it is not known whether stimulation with APLs will activate autoreactive T cells or a distinct population of cells. In the present study, 18 T-cell clones that reacted with either MBP p85-99 or one of three APLs of the peptide substituted at TCR contact residues were generated. T-cells were tested functionally for their reactivity to the original stimulating peptide as well as to the MBP APLs, In addition, the T-cell receptor (TCR) alpha and beta chains of each of these clones were sequenced. In a series of T-cell clones isolated hom a multiple sclerosis patient, stimulation of T-cells with the APL 93A, which has an alanine for lysine substitution at the TCR contact residue 93, did not induce substantial proliferation of MBPp85-99-specific T-cell clones, indicating that a distinct set of T-cell clones was induced. However, this was not the case for another set of T-cell clones from a different individual in which the 93A peptide induced clonal expansion of T-cells highly reactive with the native MBPp85-99 antigen. Thus, the potential beneficial effect of using APLs to induce downregulatory cytokines appears to depend on the specific T-cell repertoire of the individual patient. (C) 1999 Academic Press.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 32 条
[11]   Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 [J].
Garboczi, DN ;
Ghosh, P ;
Utz, U ;
Fan, QR ;
Biddison, WE ;
Wiley, DC .
NATURE, 1996, 384 (6605) :134-141
[12]  
GARCIA KC, 1996, SCIENCE, V274, P176
[13]   ELIMINATION FROM PERIPHERAL LYMPHOID-TISSUES OF SELF-REACTIVE LYMPHOCYTES-B RECOGNIZING MEMBRANE-BOUND ANTIGENS [J].
HARTLEY, SB ;
CROSBIE, J ;
BRINK, R ;
KANTOR, AB ;
BASTEN, A ;
GOODNOW, CC .
NATURE, 1991, 353 (6346) :765-769
[14]  
JARAQUEMADA D, 1990, J IMMUNOL, V145, P2880
[15]   REVERSAL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY A SOLUBLE PEPTIDE VARIANT OF A MYELIN BASIC-PROTEIN EPITOPE - T-CELL RECEPTOR ANTAGONISM AND REDUCTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
KARIN, N ;
MITCHELL, DJ ;
BROCKE, S ;
LING, N ;
STEINMAN, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2227-2237
[16]  
KUCHROO VK, 1994, J IMMUNOL, V153, P3326
[17]   Constitutive class I-restricted exogenous presentation of self antigens in vivo [J].
Kurts, C ;
Heath, WR ;
Carbone, FR ;
Allison, J ;
Miller, JFAP ;
Kosaka, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :923-930
[18]   A MYELIN BASIC-PROTEIN PEPTIDE IS RECOGNIZED BY CYTOTOXIC T-CELLS IN THE CONTEXT OF 4 HLA-DR TYPES ASSOCIATED WITH MULTIPLE-SCLEROSIS [J].
MARTIN, R ;
HOWELL, MD ;
JARAQUEMADA, D ;
FLERLAGE, M ;
RICHERT, J ;
BROSTOFF, S ;
LONG, EO ;
MCFARLIN, DE ;
MCFARLAND, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :19-24
[19]   ADOPTIVE TRANSFER OF MYELIN BASIC PROTEIN-SENSITIZED T-CELLS PRODUCES CHRONIC RELAPSING DEMYELINATING DISEASE IN MICE [J].
MOKHTARIAN, F ;
MCFARLIN, DE ;
RAINE, CS .
NATURE, 1984, 309 (5966) :356-358
[20]   A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens [J].
Nicholson, LB ;
Murtaza, A ;
Hafler, BP ;
Sette, A ;
Kuchroo, VK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9279-9284